UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (8415) 8415
life sciences & biomedicine (7223) 7223
humans (5382) 5382
animals (4807) 4807
wnt protein (3401) 3401
signal transduction (3034) 3034
mice (2628) 2628
cell biology (2353) 2353
β-catenin (2273) 2273
oncology (2198) 2198
beta catenin - metabolism (2189) 2189
gene expression (2128) 2128
wnt signaling pathway - drug effects (1991) 1991
wnt proteins - metabolism (1953) 1953
proteins (1933) 1933
wnt (1794) 1794
female (1777) 1777
stem cells (1713) 1713
cell line, tumor (1685) 1685
male (1658) 1658
cancer (1621) 1621
apoptosis (1472) 1472
biochemistry & molecular biology (1457) 1457
cell proliferation (1421) 1421
wnt signaling pathway (1395) 1395
kinases (1385) 1385
signaling (1169) 1169
science & technology - other topics (1164) 1164
multidisciplinary sciences (1134) 1134
cell proliferation - drug effects (1101) 1101
research (1072) 1072
research article (1049) 1049
tumors (1047) 1047
signal transduction - drug effects (1038) 1038
medicine (1031) 1031
cells, cultured (944) 944
analysis (916) 916
beta catenin - genetics (910) 910
science (835) 835
metastasis (808) 808
wnt signaling (789) 789
cell cycle (788) 788
wnt proteins - genetics (787) 787
cell growth (769) 769
medicine, research & experimental (767) 767
research & experimental medicine (767) 767
biology (762) 762
rats (757) 757
genetic aspects (746) 746
mutation (741) 741
genes (736) 736
cell differentiation (732) 732
colorectal cancer (705) 705
phosphorylation (688) 688
apoptosis - drug effects (668) 668
rodents (668) 668
cell differentiation - drug effects (666) 666
health aspects (664) 664
cell line (645) 645
pharmacology & pharmacy (645) 645
gene expression regulation, neoplastic (600) 600
physiological aspects (582) 582
wnt signaling pathway - genetics (581) 581
breast cancer (557) 557
antineoplastic agents - pharmacology (547) 547
middle aged (537) 537
development and progression (522) 522
disease models, animal (522) 522
transcription factors (518) 518
studies (513) 513
mice, inbred c57bl (512) 512
wnt proteins (505) 505
neurosciences (504) 504
developmental biology (503) 503
signal transduction - physiology (499) 499
wnt signaling pathway - physiology (498) 498
differentiation (482) 482
metastases (476) 476
cancer therapies (470) 470
cell adhesion & migration (464) 464
care and treatment (460) 460
cell migration (460) 460
mesenchyme (454) 454
neurosciences & neurology (452) 452
wnt/β-catenin (449) 449
chemotherapy (448) 448
adult (445) 445
physiology (443) 443
tumorigenesis (443) 443
endocrinology & metabolism (441) 441
immunohistochemistry (435) 435
ligands (428) 428
inflammation (419) 419
review (410) 410
genetics & heredity (406) 406
genetics (400) 400
transcription (395) 395
medical prognosis (394) 394
biochemistry (390) 390
blotting, western (388) 388
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (9807) 9807
Chinese (91) 91
Japanese (37) 37
Portuguese (12) 12
French (4) 4
Norwegian (4) 4
German (2) 2
Russian (2) 2
Spanish (2) 2
Amharic (1) 1
Hungarian (1) 1
Italian (1) 1
Korean (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Molecular medicine reports, ISSN 1791-2997, 09/2015, Volume 12, Issue 3, pp. 4530 - 4537
... cancer to chemotherapy drugs, including cisplatin and tyrosine kinase inhibitors (TKI), is a significant factor influencing disease prognosis. Therefore, exploration... 
A549/DDP | Lung cancer | Cisplatin | Maternally expressed gene 3 | Cell cycle | Apoptosis | Oncology | Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Research & Experimental Medicine | Lung Neoplasms - drug therapy | RNA, Small Interfering - genetics | Epithelial Cells - metabolism | Apoptosis - drug effects | Inhibitor of Apoptosis Proteins - genetics | Epithelial Cells - drug effects | Humans | Lung Neoplasms - metabolism | Middle Aged | Gene Expression Regulation, Neoplastic | Lung Neoplasms - pathology | Male | Tumor Suppressor Protein p53 - genetics | Adaptor Proteins, Signal Transducing - antagonists & inhibitors | Aged, 80 and over | Female | Antineoplastic Agents - pharmacology | Inhibitor of Apoptosis Proteins - metabolism | Lung - metabolism | Wnt Signaling Pathway | Carcinoma, Non-Small-Cell Lung - pathology | Lung Neoplasms - genetics | Lung - pathology | Carcinoma, Non-Small-Cell Lung - genetics | Carcinoma, Non-Small-Cell Lung - metabolism | Tumor Suppressor Protein p53 - metabolism | Epithelial Cells - pathology | RNA, Long Noncoding - genetics | Cisplatin - pharmacology | beta Catenin - metabolism | beta Catenin - genetics | Drug Resistance, Neoplasm - genetics | Cell Cycle Checkpoints - drug effects | Lung - drug effects | Adaptor Proteins, Signal Transducing - genetics | Cell Line, Tumor | Aged | Cell Proliferation - drug effects | Carcinoma, Non-Small-Cell Lung - drug therapy | Adaptor Proteins, Signal Transducing - metabolism | RNA, Long Noncoding - metabolism | Drug Resistance, Neoplasm - drug effects | RNA, Small Interfering - metabolism
Journal Article
Molecular neurobiology, ISSN 1559-1182, 09/2014, Volume 52, Issue 1, pp. 638 - 652
...Neuroprotective Role of Novel T riazine Derivatives by Activating Wnt/β Catenin Signaling Pathway in Rodent Models of Alzheimer’sD i s e a s e Anshuman Sinha... 
Aβ 1–42 | Neurology | β-catenin | Neuroprotection | Neurosciences | Biomedicine | Alzheimer’s disease | Wnt pathway | Neurobiology | Triazine | Cell Biology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Memory - drug effects | Neuroprotective Agents - therapeutic use | Neurons - pathology | Rats, Wistar | Triazines - therapeutic use | Apoptosis - drug effects | Caspase 3 - metabolism | Nerve Degeneration - physiopathology | Male | Alzheimer Disease - pathology | Butyrylcholinesterase - chemistry | Neuroprotective Agents - pharmacology | Butyrylcholinesterase - metabolism | Amyloid beta-Peptides | Triazines - chemistry | Neurons - metabolism | Neurons - drug effects | Disease Models, Animal | Alzheimer Disease - physiopathology | Triazines - pharmacology | Scopolamine | Cytochromes c - metabolism | Alzheimer Disease - drug therapy | Hippocampus - pathology | Acetylcholinesterase - chemistry | Antioxidants - pharmacology | Glycogen Synthase Kinase 3 - metabolism | Maze Learning - drug effects | beta Catenin - metabolism | Nerve Degeneration - pathology | Animals | Wnt Signaling Pathway - drug effects | Cholinesterase Inhibitors - pharmacology | Alzheimer Disease - metabolism | Mice | Molecular Docking Simulation | Oxidative Stress - drug effects | Cholinesterase Inhibitors - therapeutic use | Acetylcholinesterase - metabolism | Nerve Degeneration - drug therapy | Index Medicus
Journal Article
by Liu, C and Wang, L and Zhu, R and Liu, H and Ma, R and Chen, B and Li, L and Guo, Y and Jia, Q and Shi, S and Zhao, D and Mo, F and Zhao, B and Niu, J and Fu, M and Orekhov, A.N and Brömme, D and Gao, S and Zhang, D
Osteoporosis international, ISSN 1433-2965, 08/2018, Volume 30, Issue 2, pp. 491 - 505
...) rats and identify the signaling pathway involved in this process.OVX rats were treated with RRP aqueous extract for 14 weeks... 
Cathepsin K | Medicine & Public Health | Orthopedics | Wnt/β-catenin | Rheumatology | Ovariectomized (OVX) rats | Bone quality | Rehmanniae Radix Preparata (RRP) | OPG/RANKL | Endocrinology | Life Sciences & Biomedicine | Endocrinology & Metabolism | Science & Technology | Femur - pathology | Bone Density - physiology | Drugs, Chinese Herbal - pharmacology | Wnt Signaling Pathway - physiology | Osteoporosis - drug therapy | Weight Gain - physiology | Bone Remodeling - physiology | X-Ray Microtomography | Bone Remodeling - drug effects | Osteoporosis - metabolism | Biomechanical Phenomena - drug effects | Absorptiometry, Photon - methods | Female | Weight Gain - drug effects | Drugs, Chinese Herbal - therapeutic use | Osteoporosis - physiopathology | Disease Models, Animal | Drug Evaluation, Preclinical - methods | Ovariectomy | Bone Density Conservation Agents - therapeutic use | Femur - drug effects | Femur - physiopathology | Rats, Sprague-Dawley | beta Catenin - metabolism | Bone Density Conservation Agents - pharmacology | Bone Density - drug effects | Animals | Wnt Signaling Pathway - drug effects | Rehmannia | Alkaline phosphatase | Femur | Insulin-like growth factor I | Homeostasis | Insulin-like growth factors | Drug development | Kinases | Phosphatase | Signal transduction | Computed tomography | Rodents | Bone loss | Bone (cortical) | Bone strength | Enzyme-linked immunosorbent assay | Dual energy X-ray absorptiometry | Cbfa-1 protein | Glycogen | Glycogen synthase kinase 3 | Mechanical properties | Bone turnover | Osteoclastogenesis | Osteoblastogenesis | Bone mineral density | Acid phosphatase (tartrate-resistant) | Dkk1 protein | Index Medicus
Journal Article
Journal Article
International journal of oncology, ISSN 1019-6439, 12/2013, Volume 43, Issue 6, pp. 1951 - 1959
Journal Article
International journal of molecular medicine, ISSN 1107-3756, 2014, Volume 34, Issue 4, pp. 1045 - 1050
Journal Article
Molecular neurobiology, ISSN 1559-1182, 07/2015, Volume 53, Issue 7, pp. 4286 - 4301
.... Currently, no information is available about the putative mechanism and neuroprotective effects of ALCAR in 6-hydroxydopamine (6-OHDA... 
Neurology | Oxidative stress | Neuroprotection | Neurosciences | Biomedicine | Neuroblasts | Neurobiology | Acetyl- l -carnitine (ALCAR) | Neural stem cells | Wnt/ β -catenin pathway | Cell Biology | Acetyl-l-carnitine (ALCAR) | Wnt/β-catenin pathway | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Neuroprotective Agents - therapeutic use | Reactive Oxygen Species - metabolism | Acetylcarnitine - pharmacology | Dopaminergic Neurons - pathology | Neuroglia - pathology | Antioxidants - metabolism | Nitrites - metabolism | Male | Parkinson Disease - drug therapy | Oxidopamine | Neuroglia - drug effects | Behavior, Animal | Brain - metabolism | Cell Nucleus - metabolism | Neuroprotective Agents - pharmacology | Dopaminergic Neurons - metabolism | Lipid Peroxidation - drug effects | Ataxia - drug therapy | Dopaminergic Neurons - drug effects | Neurogenesis - drug effects | Parkinson Disease - metabolism | Phosphorylation - drug effects | Disease Models, Animal | Parkinson Disease - complications | Parkinson Disease - pathology | Neural Stem Cells - drug effects | Axons - drug effects | Axons - metabolism | Glycogen Synthase Kinase 3 beta - metabolism | Rats, Sprague-Dawley | Brain - drug effects | Phenotype | Animals | Wnt Signaling Pathway - drug effects | Axons - pathology | Brain - pathology | Neuroglia - metabolism | Ataxia - complications | Acetylcarnitine - therapeutic use | Oxidative Stress - drug effects | Cell Nucleus - drug effects | Neural Stem Cells - metabolism | Index Medicus
Journal Article
Journal Article